# The Branded Health Service Medicines (Costs) (Amendment) Regulations 2025, Regulation 3: Amendments to regulation 3


(1) Regulation 3 (payment scheme) is amended as follows.
(2) In paragraph (1)—
(a) for “paragraphs (1AA), (4) and (5A)” substitute “paragraphs (1AA), (1AB), (4) and (5A)”; and
(b) for the table substitute the following table—
“
Table
Applicable Period
Newer presentation payment percentage
Older presentation payment percentage
1st July 2025 to the end of 2025
23.4%
10.6%
1st January 2026 to the end of 2026
24.3%
11%
1st January 2027 to the end of 2027 and any subsequent calendar year
26.0%
10.9%
”.
(3) After paragraph (1AA) insert—
“(1AB) Where paragraph (1AC) applies, the newer presentation payment percentage referred to in paragraph (1) for the period beginning on 1st July 2025 and ending at the end of 2025 is 31.3% and not 23.4%.
(1AC) This paragraph applies in the case of the payments payable under paragraph (1) by a manufacturer or supplier in respect of supplies during the period beginning on 1st July 2025 and ending at the end of 2025, if, in respect of any supply of an item of presentation that was a newer presentation of that manufacturer or supplier—
(a) a payment was payable under paragraph (1) in respect of a supply during the period beginning on 1st January 2025 and ending at the end of 30 June 2025; and
(b) the applicable payment percentage was 15.5%.”.

---
Source: https://www.legislation.gov.uk/uksi/2025/667/regulation/3 (the official version)
Page: https://openlegislation.uk/branded-health-service-medicines-costs-amendment-regulations-2025/regulation-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.